Humana (NYSE:HUM) Stock Price Expected to Rise, Guggenheim Analyst Says

Humana (NYSE:HUM) had its target price upped by Guggenheim from $471.00 to $521.00 in a report issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the insurance provider’s stock. Guggenheim‘s price target would suggest a potential upside of 20.13% from the company’s previous close.

Other equities analysts also recently issued reports about the company. Truist Financial raised their price target on Humana from $415.00 to $475.00 and gave the company a “hold” rating in a report on Monday, October 12th. HSBC lowered Humana to a “hold” rating in a research report on Thursday, July 30th. Raymond James Financial reiterated an “outperform” rating on shares of Humana in a research note on Friday. Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price objective on the stock in a research report on Thursday, July 30th. Finally, Oppenheimer raised their price objective on shares of Humana from $475.00 to $525.00 and gave the company an “outperform” rating in a research note on Monday, October 12th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $462.87.

Humana Stock Down 0.0%

HUM stock traded down $0.05 on Monday, reaching $433.69. 637,112 shares of the company traded hands, compared to its average volume of 1,637,193. Humana has a one year low of $163.11 and a one year high of $456.50. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.65 and a quick ratio of 1.74. The company has a market cap of $52.08 billion, a P/E ratio of 42.32, a price-to-earnings-growth ratio of 2.67 and a beta of 0.65. The firm has a fifty day simple moving average of $403.96 and a 200-day simple moving average of $312.27.

Humana (NYSE:HUM) last announced its quarterly earnings data on Friday, November 6th. The insurance provider reported ($0.70) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.00) by $0.30. Humana had a return on equity of 8.50% and a net margin of 0.81%. The business had revenue of $41.16 billion during the quarter, compared to analysts’ expectations of $40.87 billion. During the same quarter in the previous year, the business earned $3.24 earnings per share. The firm’s quarterly revenue was up 26.1% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.500- EPS. Research analysts anticipate that Humana will post 9.03 earnings per share for the current year.

Institutional Trading of Humana

A number of institutional investors and hedge funds have recently modified their holdings of the business. Johnson Financial Group Inc. bought a new position in shares of Humana during the second quarter valued at $26,000. Trust Co. of Vermont purchased a new stake in shares of Humana during the second quarter valued at $28,000. Bogart Wealth LLC increased its holdings in Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after buying an additional 48 shares in the last quarter. MidFirst Bank bought a new stake in Humana in the 2nd quarter worth about $35,000. Finally, Global Assets Advisory LLC bought a new stake in Humana in the 1st quarter worth about $38,000. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans.

The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Humana was founded in 1961 as a nursing home company and later expanded into health insurance.